Company led medicines recall: Respreeza 1,000 mg powder and solvent for solution for infusion (EU/1/15/1006/001)

CSL Behring UK Ltd is recalling two batches of Respreeza 1,000 mg powder and solvent for solution for infusion (EU/1/15/1006/001) as a precautionary measure, as there is a risk of potential microbial contamination due to the failure of the HEPA filters at the manufacturing site.

Medicines and Healthcare products Regulatory Agency